DermTest
Berlin · Founded 2013
About DermTest
Dermtest is a doctor-to-doctor telemedicine platform empowering family doctors to provide high quality skin-cancer early detection service. Dermtest enables discovering early changes in moles that may develop into malignant skin tumors. The system combines teledermatology software and diagnostic hardware into a complete solution, including telemedicine, m-health and personalized medicine components. The core of the Dermtest product is a teledermoscopy system with decision support, connecting family doctors with dermatologists for providing access to a dermatologist consultation at a patient’s local primary care clinic.
Company Facts
- Founded: 2013
- Legal name: Dermtest GmbH
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $54.6K
- Funding stage: Seed
- Last round: Seed (Oct 2016)
- Website: dermtest.com
- Phone: +37255612672
Social Profiles
Canonical: https://fsome.com/organization/dermtest-8366678 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.